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abjc.2013Abstract New series of Fe(II) complexes and Schiff base amino acids have been designed and syn-
thesized from the bioactive ligands by condensation of 5-bromo-2-hydroxybenzaldehyde and a-
amino acids (L-alanine (ala), L-phenylalanine (phala), L-aspartic acid (aspa), L-histidine (his) and
L-arginine (arg)). Elemental analyses, infrared, ultraviolet–visible spectra, as well as conductivity
and magnetic susceptibility measurements are used to elucidate the structure of the newly prepared
iron(II) complexes. Moreover, the stoichiometry and the stability constants of the prepared com-
plexes have been determined spectrophotometrically. The results suggest that the prepared Schiff
base amino acid ligands behave as dibasic tridentate ONO ligands and bind to Fe(II) in octahedral
geometry according to the general formula [Fe(bs:aa)2].nH2O. The DNA interaction of these com-
plexes was tested at pH = 7.2, by using electronic absorption spectra and viscosity measurements.
The experimental results indicated that the investigated complexes could bind to DNA via
intercalative mode and showed a different DNA binding activity according to the sequence:
bsari > bshi > bsali > bsasi > bsphali. Moreover, the prepared compounds are tested for their
in vitro antibacterial activity against three types of bacteria, Escherichia coli, Pseudomonas aeruginosa
and Bacillus cereus. The results show that the metal complexes are more reactive with respect to their
corresponding Schiff base ligands.
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University.o.com (A.M. Abu-Dief).
Saud University.
g by Elsevier
ng by Elsevier B.V. on behalf of K
7.010
l-Rahman, L.H. et al., DNA bind
e(II) complexes bearing ONO do
.07.0101. Introduction
Schiff base complexes possess a wide variety of activities against
bacteria (Prashanthi et al., 2008), fungi (Daniel et al., 2008), and
certain types of tumors (Galal et al., 2009). They have been used
as radiotracers in nuclear medicine and drugs (Du Preez et al.,ing Saud University.
ing ability mode, spectroscopic studies, hydrophobicity, and in vitro
nors amino acid Schiﬀ bases. Arabian Journal of Chemistry (2013),
2 L.H. Abdel-Rahman et al.1984). Some drugs show increased activity when administered as
metal chelates and inhibit the growth of tumors (You et al.,
2004). Moreover, the development in the ﬁeld of bioinorganic
chemistry has increased the interest in Schiff base complexes,
since it has been recognized that many of these complexes may
serve as models for biologically important species (Ghosh
et al., 2010; Zhong et al., 2007; Abdallah et al., 2009; Liu and
Yang, 2009; Sathisha et al., 2008). It is clear that Schiff base
transition metal complexes are very important chelates because
they are cheap, easy to synthesize and possess chemical and ther-
mal stability. Moreover, these complexes have extensive appli-
cations in the ﬁelds of medicine, photo and magnetic
chemistry (Yang et al., 2006), and electrochemistry (Chiericato
Junior et al., 2004). Schiff base amino acid complexes act as
good chelating agents (Nath and Yadov, 1997), behave as efﬁ-
cient biologically active (El-Said et al., 2001) and cytotoxic
agents (Wang et al., 2002). In addition, Schiff base amino acid
complexes are considered to constitute new kinds of potential
antibacterial and anticancer reagents (Wang et al., 2005). From
a bioinorganic point of view, iron Schiff base complexes provide
useful structural and electronic models for the similarly coordi-
nated sites found in the heme iron enzymes. Moreover, these
complexes are also important for the asymmetric oxidation of
organic substrates, since their structure and catalytic activity
are analogous with those of iron porphyrins (Canali and
Sherrington, 1999). The investigation of drug-DNA interaction
is of importance for understanding the molecular mechanism of
drug action and for the design of speciﬁc DNA-targeted drug.
The possible interaction model between small molecules and
DNA generally follows three models (i) electrostatic binding be-
tween cation species and negative charge DNA phosphate (ii)
groove binding in which molecule bound in groove of DNA
involving hydrogen bonding, van der Waals interaction force
and (iii) intercalative binding involves drug and base pairs.
Studying the interaction between transition metal complexes
and DNA has attracted many interests (Erkkila et al., 1999;
Vijayalakshmi et al., 2000; Liu et al., 2004; Wang et al., 2006;
Raman et al., 2007; Chaviara et al., 2008; Mahalakshmi and
Rajavel, 2010; Sabolova´ et al., 2011) due to their importance
in cancer therapy, design of new types of pharmaceutical mole-
cules and molecular biology. On the other hand, few studies
were carried out concerning the interaction of DNA with Schiff
base amino acid complexes (Cheng et al., 2009; Begum et al.,
2010; Jianfanga et al., 2011). In addition to, the capability of
transitionmetal complexes of cleavingDNAon irradiation with
visible light, they have important potential applications in pho-
todynamic therapy (PDT) of cancer Patra et al., 2009. PDT has
emerged as a non-invasive mode of treatment for cancer in
which selective photoactivation of the drug at the cancer cells
leads to damage of the photo-exposed cells only, leaving healthy
cells unaffected (Bonnett, 2000;Henderson et al., 2000). Bearing
the above facts in mind, and as a part of our continuing research
(Abdel-Rahman et al., 2013a), the present study deals with prep-
aration and characterization of some novel Fe(II) Schiff base
amino acid complexes. Moreover, the interaction with DNA
of the studied complexes is screened. The choice of these types
of amino acids Schiff bases under study is to be helpful to under-
stand the interaction modes and their different structural fea-
tures on the side chains that may result in different DNA
binding modes by hydrogen bonding, van der Waals force or
hydrophobic interaction. The knowledge gained from this studyPlease cite this article in press as: Abdel-Rahman, L.H. et al., DNA bind
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DNA structure and new therapeutic reagents for tumors and
other diseases as well as further understanding of the pharmaco-
logical effects of these complexes. Furthermore, In vitro antibac-
terial activity of the prepared compounds is screened. The
structures of the Schiff base amino acid ligands studied in this
investigation are shown in Scheme 1 .
2. Experimental
All the starting materials of chemicals used in this investigation
such as 5-bromo-2-hydroxybenzlaldehyde (bs), amino acids,
the metal salt (FeSO4.(NH4)2SO4.6H2O), Calf thymus DNA
(CT-DNA) and Tris[hydroxymethyl]-aminomethane (Tris)
were purchased from Sigma–Aldrich Chemie (Germany).
Spectroscopic grade ethanol and HCl products were used.
2.1. Preparation of Schiff base amino acid ligands
The investigated Schiff base ligands were synthesized accord-
ing to the literature (Sakiyan et al., 2004; Abdel-Rahman
et al., 2013b). 5 mmol of the 5-bromo-2-hydroxybenzlaldehyde
was dissolved in appropriate volume of ethanol and added to
5 mmol of each amino acid (L-alanine, L-phenylalanine,
L-aspartic acid, L-histidine, L-arginine) solution in aqueous-
ethanol mixture (50% ethanol). The mixture was reﬂuxed for
5 h and the solution was rotary evaporated to 1/4 of its origi-
nal volume and then cooled to ambient temperature. After one
day, the yellow crystals were obtained, ﬁltered off and washed
with ethanol then with diethyl ether and ﬁnally dried in vacuo
over silica gel. The obtained yield for the prepared ligands was
72–83%. The results of the elemental analysis are in Table 1.
2.2. Preparation of Fe(II) Schiff base amino acid complexes
An ethanolic solution of 5 mmol (20 ml) from each prepared
ligand was treated with ethanolic solution of 2.5 mmol
FeSO4.(NH4)2SO4.6H2O (20 ml). In order to avoid oxidation
of Fe(II), a few drops of glacial acetic acid were added (Shaker
et al., 2003). The resulting solution was stirred magnetically for
6 h under nitrogen at 25 C then evaporated over night. The
resulting solid product was ﬁltered, washed with water and
dry ether respectively and ﬁnally dried in a desiccator over
anhydrous CaCl2 at room temperature. The prepared com-
plexes were recrystallized from ethanol. The obtained yield
for the prepared complexes was 73–82%.
2.3. Physicochemical properties of the prepared ligands and their
Fe(II) complexes
All the prepared Schiff base amino acid ligands and their com-
plexes were subjected to (C, H, N and Br) elemental analysis
whichwas performedat the analytic unit of the central laboratory
of Cairo University by Elemental analyzer Perkin-Elmer model
240c. Conductivity measurements were carried out using
JENWAYconductivitymetermodel 4320 at 298 Kusing ethanol
as solvent. Magnetic moment measurements of the investigated
complexes were carried out on a vibrating sample magnetometer
(MSB-AUTO). Infrared spectra of the metal chelates were mon-
itored using Shimadzu FTIR model 8101 in the region 4000–ing ability mode, spectroscopic studies, hydrophobicity, and in vitro
nors amino acid Schiﬀ bases. Arabian Journal of Chemistry (2013),
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OH
R
OHBr
Acronym
R
Ligand Complex
bsal bsali CH3
bsphal bsphali CH2
bsas bsasi CH2COOH
bsh bshi CH2
N
HN
bsar bsari
(H2C)3 NH C NH2
NH
Scheme 1 Structures and abbreviations of the Schiff base ligands and their corresponding complexes.
Scheme 2 HBrS = 5-bromosalicylaldehyde, AA = amino acid (ala, phala, aspa, his or arg), H2L = Schiff base amino acid ligand,
Fe(HL)2 = Fe(II) Schiff base amino acid complexes (bsali, bsphali, bsasi, bshi or bsari).
DNA binding ability, spectroscopic studies, hydrophobicity, and in vitro antibacterial evaluation 3400 cm1 using dry KBr disks with a high resolution of 2 cm1.
UV–Vis spectra of the prepared ligands and their Fe(II) com-
plexes in ethanol were monitored using 10 mm matched quartz
cells on PG spectrophotometermodel T + 80. Themeasurement
of spectrum was thermostatically controlled by an ultrathermo-Please cite this article in press as: Abdel-Rahman, L.H. et al., DNA bind
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http://dx.doi.org/10.1016/j.arabjc.2013.07.010state (CRIOTERM model 190) water circulator. The values of
absorbance of 5 · 103 M of each complex were measured at dif-
ferent pHvalues. The pHvalueswere adjusted by using a series of
Britton universal buffers (Britton, 1952). pHmeasurements were
carried out using HANNA 211 pH meter at 298 K.ing ability mode, spectroscopic studies, hydrophobicity, and in vitro
nors amino acid Schiﬀ bases. Arabian Journal of Chemistry (2013),
Table 1 Analytical and physical data of the Schiff base amino acid ligands and their Fe(II) complexes.
Compound Empirical
formula
(formula weight)
Molar conductance
Km (X
1 cm2 mol1)
Magnetic
moment, BM
M. P. and
decom.
temp. (oC)
Analysis Found (Calculated)
C H N Br
bsal C10H10NO3Br (272.09) _ _ 86 44.27 3.61 5.22 29.45
(44.14) (3.70) (5.15) (29.37)
bsali C20H22FeN2O8Br2 (634.046) 37.00 4.34 190 38.11 3.43 4.29 25.11
(37.88) (3.50) (4.42) (25.20)
bsphal C16H14NO3Br (348.18) _ _ 106 55.32 4.21 3.91 22.78
(55.19) (4.12) (4.02) (22.95)
bsphali C32H32FeN2O9Br2 (804.246) 64.00 4.82 210 47.76 3.92 3.26 19.71
(47.79) (4.01) (3.48) (19.87)
bsas C11H10NO3Br (284.10) _ _ 92 46.52 3.52 4.85 27.86
(46.46) (3.55) (4.93) (27.81)
bsasi C22H20FeN2O11 Br2 (704.05) 47.50 4.03 195 37.62 2.95 3.85 22.65
(37.53) (2.86) (3.98) (22.70)
bsh C13H12N3O3Br (338.16) _ _ 110 46.28 3.46 12.31 23.75
(46.17) (3.58) (12.43) (23.63)
bshi C26H28FeN6O9Br2 (784.194) 55.10 4.55 310 40.02 3.71 10.64 20.21
(39.82) (3.60) (10.72) (20.38)
bsar C13H17N4O3Br (357.21) _ _ 101 43.86 4.73 15.81 22.44
(43.71) (4.80) (15.69) (22.37)
bsari C26H36FeN8O8Br2 (804.278) 61.00 4.75 217 39.03 4.38 13.81 19.65
(38.82) (4.51) (13.94) (19.87)
4 L.H. Abdel-Rahman et al.2.4. Solubility measurements
Solubilities of the prepared complexes were measured at
298 ± 0.1 K by agitating a generous excess of each complex
with the appropriate water–ethanol and water-dimethyl sulfox-
ide mixtures in a thermostated vessel for seven hours. This time
is enough to prepare the best saturated solution from the solid
compound in aqueous-solvent mixtures. Then portions of
supernatant from the saturated solution were removed and
centrifuged rapidly using a centrifuge before withdrawing an
aliquot by using a micropipette. The solution was diluted as
necessary. Then the absorbance was measured at kmax for each
complex (Abu-Gharib et al., 2011, 2013). All aliquots of
equilibrated solutions were diluted with the solvent and the
dependences of kmax on solvent composition, were found to
be very small for the studied complexes, and thus ignored in
calculation of solubilities. The customary precautions were
taken to avoid heating of aliquots of saturated solutions before
dilution and to prevent any solid material being carried
through with samples of saturated solutions. The spectra were
measured at different sampling times to verify a constant
concentration has been achieved. The concentrations of the
saturated solutions were determined by applying Beer’s law
(Aabs = ecl) where ‘‘e’’ is the molar extension coefﬁcient in
dm3 mol1 cm1, ‘‘c’’ is the concentration in mol dm3 and
‘‘l’’ is the length of the cell in cm. The molar extension coefﬁ-
cient ‘‘e’’ in dm3 mol1 cm1 for each complex was determined
from the least square of the standard curve using Beer’s law.
2.5. DNA binding experiments
2.5.1. Methodology for DNA binding using absorption
spectroscopic studies
All the experiments involving the interaction of the complexes
with DNA were carried out in Tris–HCl buffer (50 mM, pHPlease cite this article in press as: Abdel-Rahman, L.H. et al., DNA bind
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use. A solution of calf thymus DNA in the buffer gave a ratio
of UV absorbance at 260 and 280 nm of about >1.86, indicat-
ing that the DNA was sufﬁciently free from protein contami-
nation (Murmur, 1961; Raman et al., 2011; Abdel-Rahman
et al., 2013a,b). The concentration of DNA was determined
by monitoring the UV absorbance at 260 nm using
e260 = 6600 mol
1 cm2. The stock solution was stored at
4 C and used within only one day. Spectrophotometeric titra-
tion experiment was performed by maintaining the metal com-
plex concentration constant while varying the nucleic acid
concentration in the interaction medium. The absorption due
to free CT-DNA was eliminated by adding an equimolar
CT-DNA to pure buffer solution in the reference compartment
and the resulting spectra were considered to result from the
metal complexes and the DNA – metal complex aggregates.
From the absorption data, the intrinsic binding constant (Kb)
was determined by plotting [DNA]/(ea  ef) vs. [DNA] accord-
ing to the following equation:
½DNA
ðea  efÞ ¼
½DNA
ðeb  efÞ þ
1
½Kbðeb  efÞ
Where, [DNA] is the concentration of DNA in base pairs, ea, ef
and eb are the apparent, free and fully bound complex absorp-
tion coefﬁcients, respectively. In particular, ef was determined
from the calibration curve of the isolated metal complex; fol-
lowing the Beer’s law. ea was determined as the ratio between
the measured absorbance and the metal(II) complex concen-
tration, Aobs/[complex]. The data were ﬁtted to the above
equation with a slope equal to 1/(eb  ef) and y-intercept equal
to 1/[Kb(eb  ef)] and Kb was obtained from the ratio of the
slope to the intercept (Wolf et al., 1987). The standard Gibb’s
free energy for DNA binding was calculated from the follow-
ing relation (Sabolova´ et al., 2011):
DGb ¼ RT lnKbing ability mode, spectroscopic studies, hydrophobicity, and in vitro
nors amino acid Schiﬀ bases. Arabian Journal of Chemistry (2013),
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complexes with DNA
Viscosity measurements were carried out using an Oswald
microviscometer, maintained at constant temperature at
25 ± 1 C in thermostat. The ﬂow times were recorded for dif-
ferent concentrations of the complex (10–250 lM), maintain-
ing the concentration of DNA constant (250 lM). Mixing of
the solution was achieved by bubbling the nitrogen gas
through the viscometer. The average value of the three mea-
surements was used to determine the viscosity of the samples.
The buffer ﬂow time in seconds was recorded as t. The relative
viscosities for DNA in the presence (g) and absence (g) of the
complex were calculated using the relation g= (t  t)/t.
Where, t is the observed ﬂow time in seconds and the values
of the relative viscosity (g/g) were plotted against 1/R
(R= [DNA]/[Complex]) (Satyanarayana et al., 1992).
2.6. Antibacterial screening (in vitro)
All the synthesized Schiff base ligands and their corresponding
Fe(II) complexes were screened in vitro for their antibacterial
activity against two Gram-negative (Escherichia coli, Pseudo-
monas aeruginosa) and one Gram-positive (Bacillus cereus) bac-
terial strains using agar well diffusion method (Raman et al.,
2001). Oﬂoxacin and Ciproﬂoxacin were used as standards for
antibacterial activity. Each compound was dissolved in di-
methyl sulfoxide at different concentrations (5, 10 and 20 mg/
ml). DMSO was used as solvent and also for control. DMSO
was found to have no antimicrobial activity against any of the
test organisms. 1 cm3 of a 24 h broth culture containing
106 CFU/cm3was placed in sterile Petri-dishes.Molten nutrient
agar (15 cm3) maintained at ca. 45 C was then poured into the
Petri-dishes and allowed to solidify. Then holes of 6 mm diam-
eter were formed in the agar using a sterile cork borer and these
holes were completely ﬁlled with the test solutions. The plates
were incubated for 24 h at 37 C. The zones of inhibition based
upon zone size around the wells were measured.
3. Results and discussion
3.1. Characterization of the prepared complexes
3.1.1. Melting points and decomposition temperature
measurements
The prepared complexes are stable in the air. The decomposi-
tion temperature of all prepared complexes is higher than the
reported melting points of the Schiff base ligands, so it is dif-
fering from all reagents used in the preparation (cf. Table 1).
This can be used as an evidence for the higher thermal stability
of reagents via complexation with the Fe(II) ion Banerjee
et al., 1984 The formation of the investigated Schiff base amino
acid ligands and their complexes is represented in Scheme 2.
3.1.2. Microanalyses and molar conductance measurements
Microanalyses data of the prepared complexes are reported in
Table 1 and suggested that the Schiff base ligands act as triden-
tate and form complexes in 1:2 ratio metal to ligand. Thus the
general formula of the prepared complexes is suggested to be
[Fe(HL)2]ÆnH2O. The presence of water as crystalline water is
conﬁrmed by heating the prepared complexes at 110 C forPlease cite this article in press as: Abdel-Rahman, L.H. et al., DNA bind
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110 C, for crystallization water, were consistent with the cor-
responding microanalytical data. The following results show a
comparison between thermogaravimetric data at 110 C and
microanalytical data for crystallization water in the prepared
complexes: {bsali: 5.5 (5.68)%; bsphali: 6.75 (6.72)%; bsasi:
2.51 (2.56)%; bshi: 6.85 (6.89)%; bsari: 4.49 (4.48)%}.
Consequently the divalent anions of the Schiff base amino
acid ligand are coordinated to the central metal Fe(II) ion.
The measured molar conductance values of 103–104 molar
solutions of the prepared Fe(II) complexes in ethanol were
found to be in the range 37–64 ohm1 cm2 mol1 (cited in Ta-
ble 1) which is in agreement with the non-electrolytic nature of
the complexes (Abdel-Rahman et al., 2013a,b). The non elec-
trolytic nature of the investigated complexes is matched with
microanalytical data.
3.1.3. Magnetic moment measurements
In a magnetic ﬁeld, the paramagnetic compounds will be at-
tracted while the diamagnetic compounds repelled. For para-
magnetic substances, the ﬂux is greater within the substance
than it would be in vacuum. Therefore, paramagnetic sub-
stances will have positive susceptibilities. Thus, the magnetic
susceptibility measurements provide information regarding
the geometric structure of the complexes. Magnetic susceptibil-
ity measurements showed that the prepared complexes have
paramagnetic character and suggested high spin values (4.03–
4.75 BM) i.e., the studied Schiff base amino acid ligands are
so weak that they exhibited low t2g and eg d-splitting of the
octahedral structures of the complexes (Canpolat and Kaya,
2002; El-Tabl et al., 2008; Abdel-Rahman et al., 2013a,b).
3.1.4. Infrared spectra of the prepared ligands and their Fe(II)
complexes
The IR spectra provide valuable information regarding the
nature of functional groups attached to the metal atom (Ra-
man et al., 2007). The basic theory involved is that the stretch-
ing modes of the ligands changes upon complexation due to
weakening/strengthening of the bonds involved in the bond
formation resulting in subsequent change in the position of
the bands appearing in the IR spectrum. To achieve an idea
about the groups involved in the complex formation as well
as the inﬂuence of the electrical ﬁeld of the central metal ion
on the charge distribution within the ligand, the difference be-
tween the spectrum of the free ligand and that of the complexes
can full into three types:
i- Shift in band position
ii- Intensity changes.
iii- Band splitting and disappearance of bands and appear-
ance of new bands.
The IR spectra of the investigated complexes are compared
with those of the free ligands to determine the coordination
sites which may be involved in chelation (cf. Table 2). The ba-
sic theory involved is that the stretching modes of the ligands
change upon complexation due to weaking/strengthening of
the bonds involved in the bond formation resulting in subse-
quent change in the position of the bands appearing in the IR
spectrum. The spectrum of Schiff base ligands exhibits a
characteristic band at 3396–3446 cm1 due to the stretchinging ability mode, spectroscopic studies, hydrophobicity, and in vitro
nors amino acid Schiﬀ bases. Arabian Journal of Chemistry (2013),
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Figure 1 Molecular electronic spectra of bsali complex and its
components in ethanol at 298 K.
Table 2 The infrared absorption wave numbers (cm1) of the investigated Schiff base amino acid ligands and their Fe(II) complexes.
Compound t(OH)/H2O
stretching
t (–C‚N)
stretching
t(C = C)
stretching
t(C–H)
aromatic
stretching
t(C–H)
aliphatic
stretching
ts(COO
-) tas(COO
-) t(C–O)
phenolic
t(Fe–N) t(Fe–O) t(–NH2)
stretching
t(–NH)
stretching
Assignment
bsal 3422 (w) 1651 (s( 1463 (m) 3084 (w) 2875 (w) 1416 (m) 1593 (w) 1364 (m) – – – –
bsali 3432 (m) 1645 (s) 1462 (m) 3045 (w) 2871(w) 1374 (w) 1584(w) 1275 (m) 540(w) 478(m) – –
bsphal 3440 (w) 1659 (s) 1471 (m) 3123 (w) 2871 (w) 1408 (w) 1601 (m) 1318 (m) – – – –
bsphali 3394 (m) 1619 (s) 1451 (w) 3040 (w) 2924 (w) 1366 (w) 1548(w) 1292 (w) 548(w) 457(w) – –
bsas 3421 (m) 1638 (s) 1462 (m) 3072 (w) 2935 (w) 1462 (m) 1587 (w) 1349 (m) – – – –
bsasi 3414 (m) 1628 (s) 1454 (w) 3038 (w) 2935 (w) 1375 (m) 1556(w) 1282 (m) 553 (w) 450 (w) – –
bsh 3396 (m) 1645 (s) 1467 (m) 3035 (w) 2876 (w) 1418 (m) 1581 (w) 1351 (m) – – – 3151 (m)
bshi 3437 (m) 1630 (s) 1453 (m) 3035 (w) 2925 (w) 1360 (m) 1523(w) 1298 (w) 550 (m) 460(w) – 3130 (w)
bsar 3446 (w) 1664 (s) 1467 (m) 3045 (w) 2937 (w) 1406 (m) 1577 (w) 1374 (w) – – 3337 (m) 3147 (m)
bsari 3451 (m) 1627 (s) 1454 (m) 3031 (w) 2940 (w) 1364 (m) 1532(w) 1293 (m) 549 (w) 465 (w) 3359 (w) 3168 (m)
s = Strong, m = medium, w = weak.
6 L.H. Abdel-Rahman et al.vibration of the OH group t(OH). On the other hand, the
recorded IR spectra of all the prepared complexes (cf. Table 2)
show broad band at 3451–3414 cm1 which have been as-
signed to t(OH) stretching vibration of water molecules, in
accordance with the results of the elemental analysis listed
in Table 1 (Shaker et al., 2003; Sharma and Dubey, 1994).
The spectrum of the ligands show a sharp band at 1664–
1638 cm1, due to an azomethine group (C‚N) stretching
vibration which indicates the presence of the imine structure
(Begum et al., 2010). This band is shifted to lower wave
numbers in the spectra of all complexes (1645–1619 cm1)
indicating the involvement of the nitrogen atom of the
azomethine group in the coordination to the metal ion
(Thankamony and Mohanan, 2007; Garg et al., 2008). In
the IR spectra of the Schiff bases, the two bands appeared
at 1601–1577 and 1462–1406 cm1 are attributed to the asym-
metric and symmetric stretching vibrations of the carboxylate
group tas(COO) and ts(COO). These bands are shifted to
lower wave number values upon complexation indicating that
the oxygen atom of the carboxylate group is coordinated to
the metal ion (cf. Table 2) Sharma and Dubey, 1994; Nakamoto,
1978. It is worth noting that the asymmetric vibration band of
COO is obscured by the high intensity of band of the C‚C
stretching vibration (Teyssie and Charette, 1963; Abdel-Rahman
et al., 2013b). All Schiff base ligands showed an absorption
band in the region of 1374–1318 cm1 which can be attributed
to the stretching vibration of the phenolic (C–O) group
t(CO)(phenolic). The shifting of these bands to lower wave
number values upon complexation indicates that the oxygen
atoms of the phenolic groups are coordinated to the metal
ion (Sharma and Dubey, 1994). The bands observed in the
regions 2940–2871 and 3054–3031 cm1 can be assigned to
t(C–H) aliphatic and t(C–H) aromatic stretching vibrations,
respectively (Abdel-Mawgoud, 1998). The IR bands found
at 3359 and 3168 cm1 for the bsari complex which contains
an arginine moiety could be assigned to the presence of the
terminal guanidinium group (Ibrahim et al., 1999). Assign-
ment of the proposed coordination sites is further supported
by the appearance of two new medium bands at 553–540
and 478–450 cm1 which could be attributed to t(Fe–N)
and t(Fe–O), respectively (Thomas et al., 1995; Abdel-Rahman
et al., 2013a).Please cite this article in press as: Abdel-Rahman, L.H. et al., DNA bind
antibacterial evaluation of some new Fe(II) complexes bearing ONO do
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The electronic absorption spectra of ethanolic solutions of li-
gands and their complexes were recorded at the wavelength
range 800–200 nm and at 298 K. The absorption region, the
molar extinction coefﬁcients and the band assignment of the
different bands in the recorded spectra of the complexes were
resulted from Figs. 1, 2). The ligand exhibits absorption bands
in UV–Vis region around 380 and 410 nm which is assigned to
nﬁ p* transition originating from the amide or imine function
of the Schiff base ligand (Ahmad et al., 2002). Another band is
observed below 306 nm, this band is assigned to pﬁ p* tran-
sition. The spectra of the complexes are dominated by intense
intraligand bands centered at kmax = 368–398 nm
(emax = 2744–1310 mol
1 cm2) and charge transfer bands cen-
tered at 428–440 nm (emax = 1518–824 mol
1 cm2), since it is
known that metal/metalloids are capable of forming dp–pp
bonds with ligands containing nitrogen and oxygen as donor
atoms (West and Nasar, 1999). Furthermore, the LﬁMCT
band is followed by a long and a broad band lying in the re-
gion 458–494 nm (emax = 2650–900 mol
1 cm2). This band
could be mainly attributed to the dﬁ d transition in the octa-
hedral structure of the prepared complexes (Shaker et al.,
2003; Lever, 1968; Abdel-Rahman et al., 2013b).ing ability mode, spectroscopic studies, hydrophobicity, and in vitro
nors amino acid Schiﬀ bases. Arabian Journal of Chemistry (2013),
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Figure 2 Molecular electronic spectra of bsphali complex and its
components in ethanol at 298 K.
Figure 3 Continuous variation plots for the prepared complexes
in aqueous-alcoholic mixture at [bsali] = 2 · 103 M, [bsphal-
i] = 1 · 103 M, [bsasi] =5 · 103 M, [bshi] = 1 · 103 M, [bsar-
i] = 1 · 103 M and 298 K.
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complexes
The spectrophotometric methods were utilized to establish the
stoichiometry of various Schiff base amino acid complexes.
The simplest spectrophotometric technique adopted to study
the equilibria in solutions of complex compounds, is the molar
ratio method (Yoe and Jones, 1944; El-Shiekh et al., 2011;
Shah and Parmar, 2011) and the continuous variation method
(Shah and Parmar, 2011; Job, 1928), as shown in Fig. 3. The
results suggest the possible formation of 1:2 complexes as pre-
sented in Scheme 3. The curves of the continuous variation
method (Fig. 3) displayed maximum absorbance at mole frac-
tion Xligand = 0.65–0.7 indicating the formation of complexes
with metal ion to ligand ratio 1:2. Moreover, the data resulted
from applying the molar ratio method support the same metal
ion to ligand ratio of the prepared complexes (see supplemen-
tary material) (see Fig. 1).
3.1.6.1. Evaluation of the apparent formation constants of the
synthesized complexes. The formation constants (Kf) of the
studied Fe(II) Schiff base amino acid complexes formed in
solution were obtained from the spectrophotometric measure-
ments by applying the continuous variation method (Shaker
et al., 2003; Issa et al., 2006) (cf. Table 3) according to the fol-
lowing relation:nH2O
Br
N
O
H
N
O
OOC
Fe
R
H
Br
H
COOH
R
Scheme 3 The suggested structures of bsali, bsphali, bsasi, bshi
complexes, bsali: n= 2, bsphali and bshi: n= 3, bsasi: n= 1 (R
as shown in Scheme 1).
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Where, Am is the absorbance at the maximum formation of the
complex, A is the arbitrary chosen absorbance values on either
side of the absorbance mountain col (pass) and C is the initial
concentration of the metal. As mentioned in Table 3, the ob-
tained Kf values indicate the high stability of the prepared
complexes. The values of Kf for the studied complexes increase
in the following order: bsari > bsali > bsphal-
i > bshi > bsasi. Moreover, the values of the stability con-
stant (pK) and Gibbs free energy (DG„) of the investigated
complexes are cited in Table 3. The negative values of Gibbs
free energy mean that the reaction is spontaneous and
favorable.
The pH-proﬁle (absorbance vs. pH) presented in Fig. 4
showed typical dissociation curves and a wide stability pH
range (4–10) of the studied complexes. This means that the for-
mation of the complex greatly stabilizes the Schiff base amino
acid ligands. Consequently, the suitable pH range for the dif-
ferent applications of the prepared complexes is from
pH= 4 to pH= 10.
Based on the results of elemental analysis, molar conduc-
tance, magnetic susceptibility, infrared and electronic
spectra, the suggested structure of the complexes is shown in
Scheme 3, 4 .Table 3 The formation constant (Kf), stability constant (pK)
and Gibbs free energy (DG„) values of the synthesized
complexes in aqueous-ethanol at 298 K.
Complex Type of
complex
Kf pK DG
„ kJ mol1
bsali 1:2 3.22 ± 0.02 · 109 9.98 57.03
bsphali 1:2 3.67 ± 0.02 · 109 9.67 54.56
bsasi 1:2 1.31 ± 0.02 · 109 8.86 50.57
bshi 1:2 1.18 ± 0.02 · 1010 8.96 51.13
bsari 1:2 3.15 ± 0.02 · 109 10.44 59.55
ing ability mode, spectroscopic studies, hydrophobicity, and in vitro
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Figure 4 Dissociation curves of the prepared bromosalicylidene
Schiff base amino acid Fe(II) complexes in aqueous alcoholic
mixture at [complex] = 5 · 103 M and 298 K.
O
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CHN
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NH2H2N
HN
C
H2N
NH2
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Scheme 4 The suggested structure for bsari complex.
Table 4 Solubility (mol dm3) values of the prepared com-
plexes in different ratios (v/v) of EtOH and DMSO at 298 K.
Solvent Complex 104 Solubility mol dm3
0 20 40 60
EtOH bsali 1.89 4.97 11.30 16.80
bsphali 0.25 0.90 5.59 9.76
bsasi 2.10 4.12 8.43 15.18
bshi 0.41 1.25 2.75 7.50
bsari 1.40 3.92 8.92 14.50
DMSO bsali 1.89 7.75 14.42 22.51
bsphali 0.25 3.75 10.61 13.96
bsasi 2.10 7.55 11.46 20.39
bshi 0.41 3.91 5.89 11.15
bsari 1.40 6.85 12.34 19.40
Table 5 Transfer chemical potential values (dml
h, kJ mol1)
of the prepared complexes in different ratios (v/v) of EtOH and
DMSO at 298 K.
Solvent Complex dml
h kJ mol1
20 40 60
EtOH bsali 2.42 4.43 5.42
bsphali 3.16 7.7 9.05
bsasi 1.67 3.45 4.9
bshi 2.76 4.72 7.21
bsari 2.55 4.57 5.8
DMSO bsali 3.5 5.04 6.14
bsphali 6.71 9.29 9.97
bsasi 3.17 4.21 5.64
bshi 5.59 6.61 8.19
bsari 3.94 5.4 6.52
8 L.H. Abdel-Rahman et al.3.1.7. Effect of hydrophilic/hydrophobic character of the
investigated complexes on their solubilities
The hydrophobicity of the investigated Fe(II) Schiff base ami-
no acid complexes can be rationalized to the low solubility of
the investigated complexes in aqueous medium (cf. Tables 4).
Moreover, the results of negative values transfer chemical
potentials of CQ*** the investigated Fe(II) Schiff base amino
acid complexes in (cf. Table 5) can mainly be ascribed to of the
hydrophobic nature of the investigated complexes. It observed
that the hydrophobicity of the investigated complexes leads to
stabilization of them with increasing solvent percent. The or-
der of hydrophobicity can increase in the direction:
bsasi < bsali < bsari < bshi < bsphali
Thus the results show preferential solvation by the solvent as
molecule size increases. Also the order of hydrophobicity of
bromosalicylidene Schiff base amino acid complexes could be
attributed to the effect complexes.
3.1.7.1. Effect of solvent polarity on the values of transfer
chemical potentials of the studied complexes. The dielectric con-
stant (D) is obviously an important factor in determining the
ease of dissolution of a compound. A high dielectric constant
seems to be a necessary requirement, but by no means the onlyPlease cite this article in press as: Abdel-Rahman, L.H. et al., DNA bind
antibacterial evaluation of some new Fe(II) complexes bearing ONO do
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hydrogen cyanide have higher dielectric constants than water.
Solvent ‘electrostatic factors’, equal to the product of dielectric
constant and dipole moment, have found use in classifying sol-
vents in respect to their dissolving powers and other properties.
The polarity, dipole moment, polarizability and hydrogen
bonding of a solvent determine its ability to solvate the
charged and none charged compounds. By comparison of
the values of transfer chemical potentials (cf. Tables 4 and 5)
of the studied complexes between aqueous-solvent mixtures,
it was observed that the investigated complexes are more sta-
bilized by increasing solvent%. This is due to the hydrophobic-
ity of these compounds, where the polarity of the used solvents
increases in the order: water > ethanol > dimethysulfoxide.
Thus the order of stabilization of the investigated complexes
with increasing the ratio of solvent is: water < ethanol <
dimethysulphoxide.
3.2. DNA-binding study
Titration with electronic absorption spectroscopy is an effec-
tive method to investigate the binding mode of DNA with me-
tal complexes (Kelly et al., 1985). The spectra were recorded as
a function of the addition of the buffer solutions of pretreated
CT-DNA to the buffer solutions of the metal complexes. If the
binding mode is intercalation, the orbital of the intercalated li-
gand can couple with the orbital of the base pairs, reducing theing ability mode, spectroscopic studies, hydrophobicity, and in vitro
nors amino acid Schiﬀ bases. Arabian Journal of Chemistry (2013),
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coupling orbital is partially ﬁlled by electrons, it results in
decreasing the transition probabilities and resulting in hypo-
chromism (Pyle et al., 1989). The extent of the hypochromism
or hyperchromism in the metal-to-ligand charge transfer
(MLCT) band is commonly consistent with the strength of
intercalative interaction (Liu et al., 2005). The electronic
absorption spectra of bsali and bsasi complexes in the absence
and presence of different concentrations of buffered CT-DNA
are given in Fig. 5. By adding DNA, the absorption intensities
of MLCT band are gradually increased. Moreover, addition of
increasing amounts of CT-DNA resulted in a decrease of
absorbance for each investigated complex. Representative
spectra illustrating this hypochromicity and the presence of
isosbestic points observed for the interaction of bsali and
bsasi with CT-DNA are given in (cf. Fig. 5 and Fig. 2 in
supplementary material). The spectral parameters for the
DNA interaction with the prepared complexes are shown in
Table 6. It can be realized from the high percent of hyper-
chromicity that the high strength binding of the prepared com-Figure 5 (a) Spectrophotometeric titration of bsasi complex
(104 M) in 0.01 M Tris buffer (pH 7.5, 25 C) with CT DNA
(from top to bottom, 0–40 lM DNA, at 5 lM intervals). (b) Plot
of [DNA]/(eaef) vs. [DNA] for the titration of DNA with bsasi
complex.
Table 6 Spectral parameters for DNA interaction with the synthes
Compound kmax free (nm) kmax bound (nm) Dn (nm) Ch
bsali 494 488 6 15.
426 384 42 76.
bsphali 500 492 8 4.9
432 398 34 49.
bsasi 490 476 14 4.6
454 392 62 51.
bshi 486 484 2 2.7
422 392 80 10.
bsari 492 490 2 4.7
432 364 68 49.
a Chromism(%)= (AfreeAbound)/ Afree [Ref 62].
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to DNA via an intercalative mode with the sequence: bsar-
i > bshi > bsali > bsasi > bsphali. The results revealed that
the structure differences of the amino acids might lead to obvi-
ous difference of DNA binding abilities of the complexes. The
high binding constant of bsari complex could be attributed to
two types of interaction modes one of them is intercalation
through insertion of an aromatic ring and the other one is
hydrogen and electrostatic bonding of the guanidinium group
of bsari with DNA.
In order to further clarify the interaction nature between
the prepared complexes and DNA, viscosity measurements
were carried out. Optical photophysical probes provide neces-
sary data but not sufﬁcient evidence to support a binding mode
of DNA with the metal complexes. Hydrodynamic methods
such as viscosity measurements which are sensitive to length
increase or decrease of DNA are regarded as the most effective
means of studying the binding mode of complexes to DNA in
the absence of crystallographic structural data and NMR
(Baguley and LeBret, 1984). For further clariﬁcation of the
binding mode, viscosity measurements were carried out. Under
appropriate conditions, a classical intercalative mode such as
intercalation of drugs like ethidium bromide (EB) causes a sig-
niﬁcant increase in the viscosity of DNA solution due to an in-
crease in the separation of base pairs at the intercalation site
and hence an increase in the overall DNA length. On other
hand, drug molecules binding exclusively to the DNA grooves
cause less pronounced, or no obvious change, in DNA solution
viscosity (Liu et al., 2008) a partial and/or nonclassical interca-
lation of complex may bend the DNA helix, resulting in the de-
crease of its effective length and, concomitantly, its viscosity
(Shi et al., 2006).
The relative viscosity of DNA solution increases signiﬁ-
cantly as the amount of the complex increases, as shown in
Fig. 6. This may be due to the insertion of the aromatic ring
in Schiff base ligand into the DNA base pairs resulting in a
bend in the DNA helix, hence, increase in the separation of
the base pairs at the intercalation site and increasing in
DNA molecular length (cf. Scheme 5). Moreover, the sequence
of the observed increase in the values of viscosity was corre-
lated with the binding afﬁnity to DNA i.e. bsari shows the
highest binding afﬁnity to DNA and the highest viscosity.
The information obtained from this work could be helpful to
the understanding of the mechanism of the interaction of
small molecules with nucleic acids, and should be useful inized complexes.
romism (%)a Type of
chromism
Binding constant
Kb · 104 M1
DG„ kJ mol1
97 Hypo 6.70 ± 0.01 27.53
75 Hyper
8 Hypo 5.79 ± 0.01 27.17
26 Hyper
6 Hypo 6.23 ± 0.01 27.35
27 Hyper
2 Hypo 7.04 ± 0.01 27.65
19 Hyper
9 Hypo 10.70 ± 0.01 28.69
32 Hyper
ing ability mode, spectroscopic studies, hydrophobicity, and in vitro
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Figure 6 The effect of increasing the amount of the synthesized
complexes on the relative viscosities of DNA at [DNA] = 0.5 mM,
[complex] = 25–250 lM and 298 K.
10 L.H. Abdel-Rahman et al.the development of potential probes of DNA structure and
conformation.
3.3. Biological activity
The contribution of the ﬁeld of bioinorganic chemistry is
important, consequently, the synthesized Schiff base amino
acid and their Fe(II) complexes have been evaluated for their
antimicrobial actions. The susceptibilities of certain strains ofScheme 5 Schematic diagram illustrating the prepared
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evaluated by measuring the size of the bacteriostatic diameter.
The antimicrobial activity data of all synthesized compounds
are summarized in Table 7 and show that the newly synthe-
sized ligands and their Fe(II) complexes possess biological
activity. The antibacterial screening results exhibited a marked
enhancement in activity on coordination with the metal ions
against one or more testing bacterial strains (cf. Fig. 7). This
enhancement in the activity can be rationalized to the basis
of the structures of the ligands that possessing an additional
azomethine (C‚N) linkage which is important in elucidating
the mechanism of transamination and resamination reaction
in biological system (Nishat et al., 2010). It has also been sug-
gested (Avajia et al., 2009; Chohan et al., 2004) that the ligands
with nitrogen and oxygen donor systems might inhibit enzyme
production, since the enzymes which require these groups for
their activity appear to be especially more susceptible to deac-
tivation by the metal ions upon chelation. The polarity of the
metal ion is reduced by chelation (Rehman et al., 2005) and
this is mainly because of the partial sharing of its positive
charge with the donor groups and possibly with the delocalized
p – electrons within the whole chelation ring, which is formed
because of the coordination. This process of chelation in-
creases the lipophilic nature of the central metal atom, which
in turn favors its permeation through the lipoid layer of the
membrane (Chohan et al., 2006). This is also responsible for
the increasing of the hydrophobic character and liposolubility
of the molecules in crossing the cell membrane of the microor-
ganism and hence enhances the biological utilization ratio and
activity of the testing drug/compound. Moreover, it was foundcomplexes intercalating into CT DNA base pairs.
ing ability mode, spectroscopic studies, hydrophobicity, and in vitro
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Table 7 Results of antimicrobial activity of the prepared ligands and their Fe(II) complexes in DMSO.
Bacteria [Comp] (mg/ml) Aa Ba bsal basli bsphal bsphali bsas bsasi bsh bshi bsar bsari
Compound (zone of inhibition in mm)
P. aeruginosa 5 9 8 – 7 – 5 2 9 1 8 1 9
10 13 12 4 9 2 6 6 13 5 11 4 12
20 16 17 7 12 4 11 7 15 8 15 7 15
E. coli 5 10 11 – 8 – 7 2 9 3 11 3 11
10 14 13 5 11 3 8 8 14 6 14 5 14
20 22 23 8 14 6 12 10 18 10 19 7 15
B. cereus 5 18 19 4 19 5 15 3 11 4 12 3 12
10 23 24 7 24 7 18 5 15 6 15 5 15
20 38 40 12 36 9 28 7 20 8 19 8 17
a A = Oﬂoxacin, B = Ciproﬂoxacin.
Figure 7 Photograph showing the antibacterial effect of bsphali,
bsasi bshi and bsari complexes on Bacillus cereus.
DNA binding ability, spectroscopic studies, hydrophobicity, and in vitro antibacterial evaluation 11that the prepared compounds show moderate to high activity
compared to the standard drugs used in the investigation (cf.
Table 7).
4. Conclusion
Binary iron(II) Schiff base amino acid complexes having ﬁve
essential amino acids, namely, alanine, phenylalanine, aspartic
acid, histidine and arginine were prepared and characterized
by different techniques such as elemental analysis, conduc-
tance measurements, magnetic susceptibility, thermogravimet-
ric analysis, electronic and IR spectra. In these complexes, the
tri-dentate Schiff base ligand is coordinated to Fe(II) ion
through phenolic-oxygen atoms, azomethine-nitrogen atom
and carboxylate–oxygen atom forming stable octahedral
complexes with the general formula [Fe(HL)2]ÆnH2O. The
suggested formulas were conﬁrmed by applying the molar ratio
and continuous variation methods. Moreover, the obtained
Kf values indicate the high stability of the prepared com-
plexes and their values increase in the following order: bsar-
i > bali > bsphali > bshi > bsasi. The cationic pendant
groups in the crescent-shaped structure of bsari have structuralPlease cite this article in press as: Abdel-Rahman, L.H. et al., DNA bind
antibacterial evaluation of some new Fe(II) complexes bearing ONO do
http://dx.doi.org/10.1016/j.arabjc.2013.07.010similarity with the antitumor antibiotic netropsin in binding to
DNA. Furthermore, The DNA binding study takes place via
an intercaltive mode. These ﬁndings clearly indicate that tran-
sition metal based complexes have many potential practical
applications, like the development of nucleic acid molecular
probes and new therapeutic reagents for diseases. Also the pre-
pared compounds show antibacterial activity.Acknowledgement
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